Intellia Therapeutics, Inc.

Direct answer

Intellia Therapeutics, Inc. is publicly traded on NASDAQ under the ticker NTLA.

Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing. The company's pipeline includes several in vivo (administered within the body) programs. NTLA-2001 is currently undergoing a Phase 1 clinical trial for transthyretin amyloidosis, while NTLA-2002 targets hereditary angioedema. Additionally, Intellia is developing various other...

Can you invest in Intellia Therapeutics, Inc.?

Yes. Intellia Therapeutics, Inc. trades publicly on NASDAQ as NTLA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Intellia Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.